KalVista Pharmaceuticals (KALV) EBIT Margin (QoQ) (2014 - 2025)
KalVista Pharmaceuticals (KALV) EBIT Margin (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 38,225.00 |
| Apr 30, 2020 | 57,262.00 |
| Jan 31, 2020 | -56,988.00 |
| Oct 31, 2019 | 4,692.00 |
| Jul 31, 2019 | 10,094.00 |
| Apr 30, 2019 | -21,362.00 |
| Jan 31, 2019 | -8,371.00 |
| Oct 31, 2018 | 10,102.00 |
| Jul 31, 2018 | -12,717.00 |
| Apr 30, 2018 | 12,510.00 |
| Jan 31, 2018 | 34,035.00 |
| Oct 31, 2017 | 515,341.00 |
| Jul 31, 2017 | -121,880.00 |
| Apr 30, 2017 | -118,842.00 |
| Jan 31, 2017 | -122,984.00 |
| Oct 31, 2016 | -151,802.00 |
| Mar 31, 2016 | -1.37 Mn |
| Dec 31, 2015 | -957,143.00 |
| Sep 30, 2015 | 1.10 Mn |
| Jun 30, 2015 | -1.09 Mn |